CytomX Therapeutics Lands $30,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c6758873-dd35-4174-bee7-c7933696d5f9&Preview=1 -
Date
9/23/2010 -
Company Name
CytomX Therapeutics -
Mailing Address
460 Ward Dr. Santa Barbara, CA 93111 -
Company Description
CytomX Therapeutics is an early stage, privately-funded biotechnology company developing Probodies, proteolytically-activated antibodies. -
Website
http://www.cytomx.com -
Transaction Type
Venture Equity -
Transaction Amount
$30,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds from the financing will be used to advance the company’s unique antibody platform, expand the team and move the company to the Bay Area by the end of 2010. -
M&A Terms
-
Venture Investor
Third Rock Ventures -
Venture Investor
Third Rock Ventures -
Venture Investor
Roche Venture Fund
